| Financial Year |
March 31 2023 |
| Monetary Funds |
269,950,524.17 |
| Held-for-trading Financial Assets |
555,670,277.62 |
| Notes Receivable |
44,232,121.94 |
| Accounts Receivable |
451,937,741.56 |
| Advances to Suppliers |
14,459,920.00 |
| Other Receivables |
36,990,070.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
129,241,476.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,218,350.32 |
| Other Current Assets |
373,407.87 |
| Total Current Assets |
1,541,615,925.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,167,250.00 |
| Long-term Equity Investment |
7,910,851.92 |
| Investment Properties |
4,128,614.52 |
| Fixed Assetes |
159,609,877.41 |
| Under-construction Projects |
19,553,512.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,386,085.98 |
| R&D expenses |
-- |
| Goodwill |
2,746,851.85 |
| Long-Term Deferred and Prepaid Expenses |
14,628.06 |
| Deferred Income Tax Assets |
41,549,062.17 |
| Other Non-Current Assets |
8,226,614.59 |
| Sub-Total of Non-Current Assets |
269,030,517.18 |
| Total Assets |
1,810,646,442.38 |
| Short-Term Loans |
10,608,955.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
155,540,878.50 |
| Accounts Payable |
85,125,364.01 |
| Accounts Received In Advance |
60,000.00 |
| Employee Compensation Payable |
109,543,311.11 |
| Taxes Payable |
11,334,483.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,298,277.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,070,296.29 |
| Other Current Liabilities |
6,041,254.54 |
| Sub-Total of Current Liabilities |
439,094,011.95 |
| Long-term Loans |
12,452,610.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,051,966.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,270,407.78 |
| Total Liabilities |
456,364,419.73 |
| Paid-In Capital(Or Share Stock) |
252,000,000.00 |
| Capital Surplus |
607,582,254.58 |
| Surplus Reserve |
55,439,062.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
436,727,832.25 |
| Minority Stockholder's Interest |
2,864,595.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,351,417,427.43 |
| Owner's Equity（Stockholder's Equity） |
1,354,282,022.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,810,646,442.38 |
